Latest Transformation News

Vection Technologies (ASX:VR1) achieved a major earnings inflection in FY26 with adjusted EBITDA soaring 596% to $3.8 million and generating positive operating cash flow for the first time, underpinned by dual commercial platforms scaling rapidly.

AUCyber Limited reported a 28% revenue decline to $19.98 million in FY26 but cut its net loss by 87% to $4.78 million, driven by exiting low-margin contracts and cost discipline. CEO Joseph Demase now also serves as Chair, steering a strategic shift towards sovereign AI and private cloud solutions.

Praemium Limited reported a 5.7% revenue increase to $110.5 million and a 21.1% jump in funds under administration to $77.9 billion for FY26, driven by strong high-net-worth segment growth and the integration of OneVue. The acquisition of Technotia Laboratories and a major technology restructure signal a sharpened focus on innovation and cost efficiency.

Argent Minerals has secured regulatory approval to launch its first-ever drilling program at the Trunkey Creek Gold Project in NSW, targeting a 4.7km high-grade gold corridor. The initial 1,000m Phase 1 campaign aims to test priority underground targets beneath historic workings.

Encounter Resources has appointed Simon Hay as Non-Executive Chairman and promoted Will Robinson to Managing Director/CEO, aligning leadership with its expanding niobium and copper-gold projects. The company’s Aileron niobium resource surged 54% in 2026, underpinning development ambitions.

Infini Resources is ramping up its exploration at the Portland Creek Uranium Project with a major 5,000-meter diamond drilling program, backed by new geophysical insights revealing a large hydrothermal system.

Strike Energy has secured Hancock Energy's Belisama facility as the preferred processing partner for West Erregulla gas and agreed on up to $30 million in funding to advance development, targeting first gas by mid-2029.

AVADA Group lifted revenue by nearly 15% in FY26, driven by Queensland and New South Wales expansion, while managing a $15 million impairment in Victoria that kept the statutory loss steady.

Cambium Bio has secured FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development costs and timelines. Despite a AUD 4.1 million loss for FY2026, the company strengthened its funding position and manufacturing partnerships ahead of patient dosing targeted for late 2026.

Orcoda Limited reported a 26% reduction in net loss and a 23% rise in Annual Recurring Revenue, boosted by a new $8 million per annum multi-year contract with Wagner Corporation, setting the stage for SaaS expansion in FY27.

Waterco Limited delivered a robust turnaround in FY26 with net profit after tax soaring 61.6% to $15.5 million on modest revenue growth. The company expanded its Swimart franchise, advanced manufacturing insourcing, and boosted dividends to 20 cents per share fully franked.

RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.